Tag Archives: Failure

Bionic pacemaker slows progression of heart failure

Using brain circuits made in silicon, scientists have alleviated symptoms of heart failure by reinstating the body’s natural heart rhythm. This study published in The Journal of Physiology today [Wednesday 13 November] holds great potential for designing more effective pacemakers in the future. In the UK alone, around 900,000 people are living with heart failure… Read More »

Why use loop diuretics in heart failure

Elevated intra-abdominal pressure has recently been debated as a causal contributor in congestion development. Should torsemide be the loop diuretic of choice in systolic heart failure? Another positive approach towards diuretic resistant heart failure is the combination of intravenous high-dose loop diuretics with hypertonic saline solutions. It may be dry and hacking, or it may… Read More »

Irish scientists create blood test that could save lives of those at highest risk of heart failure

Fast and efficient: A new blood test is being developed at Queen’s University. Photo: REUTERS Irish scientists create blood test that could save lives of those at highest risk of heart failure Independent.ie A rapid blood test that detects heart failure at an early stage has been developed by scientists in Ireland. https://www.independent.ie/irish-news/health/irish-scientists-create-blood-test-that-could-save-lives-of-those-at-highest-risk-of-heart-failure-38176982.html https://www.independent.ie/incoming/article38176428.ece/4bf11/AUTOCROP/h342/6%20NEWS%20H-HIV-PAKISTAN.jpg Email… Read More »

Weekly pharmacy visits boost drug adherence and quality of life in heart failure patients – Science Daily

Elderly patients with heart failure who see a pharmacist once a week are more likely to take their tablets and be active in daily life, according to late breaking results from the PHARM-CHF randomised controlled trial presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC). “Adhering to a… Read More »

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »